NASDAQ · STOCK
Medtronic plc
$85.39
52W $73.31 – $106.33
60/100
$109.30B
22.8
0.58
Is MDT Bullish or Bearish?
Bullish.
Innellis AI committee rates Medtronic plc (MDT) Buy with a composite score of 60/100
, based on 6 analysts with 50% agreement.
Last updated August 01, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +15.08 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -4.92 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
- Dividend yield of 3.4% pays you to wait — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.27 across 53 articles, 14d) — News
Bear Case
Insufficient data for bear case.
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 01, 2026
Overall Committee Score
60/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 19%
of 93 Healthcare peers
Value Analyst
neutral
58
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Dividend yield of 3.4% pays you to wait
Growth Analyst
bullish
62
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 53 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2535.03)
Investment Thesis Evolution
Committee score moved marginally from 57.8 to 59.9.
- Conviction changed from moderate to contested.
- Committee agreement fell notably from 67% to 50%.
- New bearish signals: 2 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance neutral->bullish; score 58->70 (+12).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
Comparing 2026-07-31 to 2026-08-01 (1 day apart).
Technical Analysis
RSI (14)
58.5
Neutral
MACD Histogram
0.300
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$85.06
Resistance
$91.49
Bollinger %B
0.76
Inside Bands
Price vs Moving Averages
EMA 9
$84.81
Above
EMA 21
$83.43
Above
EMA 50
$82.36
Above
EMA 200
$86.72
Below
Fundamental Analysis
Valuation
53
Growth
64
Profitability
0
Financial Health
98
Cash Flow
37
Valuation
P/E Ratio
22.8×
P/B Ratio
2.21×
PEG Ratio
6.89
Dividend Yield
0.03%
52W High
$106.33
52W Low
$73.31
Quality & Growth
ROE
9.7%
ROA
5.2%
Gross Margin
65.0%
Operating Margin
17.8%
Revenue Growth YoY
—
Debt / Equity
0.57
AI Fundamental Assessment
P/E ratio of 22.8 (inexpensive relative to a 15-40x range); Price-to-book of 2.2x; PEG ratio of 6.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.1%; Return on assets of 0.1%; Net margin of 0.1%; Gross margin of 0.7%; Current ratio of 2.13 (healthy short-term liquidity); Debt-to-equity of 0.57; Free cash flow margin of 0.7% (thin cash generation); Free cash flow per share is positive (4.23); Most recent quarter missed estimates by 0.4%; EPS growth accelerating (+0.0% -> +14.0% QoQ); Analyst estimates rising over recent quarters
Get the Full MDT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →